Safety of CD34(+) Hematopoietic Stem Cells and CD4(+) T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma

Although the risk of developing lymphoma has decreased in the highly active antiretroviral therapy era, this cancer remains the major cause of mortality in HIV-infected patients. Autologous hematopoietic stem cell transplantation (ASCT) outcome does not differ for HIV-infected versus HIV-uninfected...

Descripción completa

Detalles Bibliográficos
Autores principales: Delville, Marianne, Touzot, Fabien, Couzin, Chloé, Hmitou, Isabelle, Djerroudi, Lounes, Ouedrani, Amani, Lefrère, François, Tuchman-Durand, Caroline, Mollet, Chloé, Fabreguettes, Jean-Roch, Ferry, Nicolas, Laganier, Laurent, Magnani, Alessandra, Magrin, Elisa, Jolaine, Valérie, Saez-Cirion, Asier, Wolstein, Orit, Symonds, Geoffrey, Frange, Pierre, Moins-Teisserenc, Hélène, Chaix-Baudier, Marie-Laure, Toubert, Antoine, Larghero, Jérôme, Parquet, Nathalie, Brignier, Anne C., Barré-Sinoussi, Françoise, Oksenhendler, Eric, Cavazzana, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416524/
https://www.ncbi.nlm.nih.gov/pubmed/30911587
http://dx.doi.org/10.1016/j.omtm.2019.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416524/
https://www.ncbi.nlm.nih.gov/pubmed/30911587
http://dx.doi.org/10.1016/j.omtm.2019.02.006

Ejemplares similares